Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: MarketLine (a Datamonitor Company)

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Astellas Pharma Inc receives approval for additional indication for Hypnosedative, Dormicum in Japan

Friday, 20 Dec 2013 01:00am EST 

Astellas Pharma Inc:Says it received the approval of an additional indication for hypnosedative, Dormicum Injection 10 mg (generic name: midazolam) from the Ministry of Health, Labour and Welfare in Japan.Says the new indication is for use in sedation during surgery and procedures for dental, oral and maxillofacial care. 

Company Quote

-2.5 -0.18%
10:22pm EDT